icandra (previously vildagliptin / metformin hydrochloride novartis)
novartis europharm limited - вилдаглиптин, метформин хидрохлорид - Захарен диабет тип 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 и 5. 1 за наличните данни за различни комбинации).
glucose 5% + sodium chloride 0,9% baxter solution for infusion
Бакстер България ЕООД - Натриев Хлорид, Глюкоза - solution for infusion
potassium chloride + glucose kabi 1,5 mg/ml + 50 mg/ml solution for infusion
1,5 mg/ml + 50 mg/ml solution for infusion
potassium chloride + glucose kabi 3 mg/ml + 50 mg/ml solution for infusion
3 mg/ml + 50 mg/ml solution for infusion
glucose biopharm 5% solution for infusion
БИОФАРМ ИНЖЕНЕРИНГ АД - Глюкоза - 5% solution for infusion
glucose baxter 5% solution for infusion
Бакстер България ЕООД - Глюкоза - 5% solution for infusion
glucose braun 5% soltuion for injection/infusion
b.braun melsungen ag - Глюкоза - 5% soltuion for injection/infusion
glucose braun 10%solution for injection
b.braun melsungen ag - Глюкоза - 10%solution for injection
glucose baxter 10% solution for infusion
Бакстер България ЕООД - Глюкоза - 10% solution for infusion
segluromet
merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - Захарен диабет тип 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.